Developed an AI-based classification system for facial pigmented lesions
Supporting laser treatment decisions: Potential for more optimized treatment
2025-07-01
(Press-News.org)
A research team led by Haruyo Yamamoto, Chisa Nakashima, and Atsushi Otsuka from Department of Dermatology, Kindai University Faculty of Medicine, in collaboration with the Faculty of Engineering at Kindai University and other institutions, has developed a diagnostic system that uses artificial intelligence (AI) to accurately identify the type of facial pigmented lesions and support laser treatment decisions. A paper on this study was published online in Cureus, an international medical journal on June 5, 2025.
1. Key Points
Demonstrated superior diagnostic accuracy compared to dermatologists, when identifying five types of lesions, confirming the usefulness of the system in early detection and treatment decisions.
Developed a system that uses AI to accurately classify and assist in the diagnosis of five types of facial pigmented lesions that are difficult to diagnose.
Contributes to establishing a method that accurately identifies pigmented lesions, reduces the risk of mistreatment, and supports appropriate treatment decisions.
2. Research Background
Facial pigmented lesions, come in many different types, such as melasma, ephelides, acquired dermal melanocytosis, solar lentigo, and lentigo maligna melanoma, but they are often visually similar, which makes differential diagnosis challenging. On the other hand, an appropriate treatment for these lesions varies greatly depending on the type, and accurate diagnosis is essential as this directly affects the feasibility and selection of laser treatment. For example, inappropriate laser use can exacerbate melasma, and delaying necessary surgical excision for lentigo maligna melanoma due to misdiagnosis can have severe consequences. In recent years, imaging diagnostic technology using deep learning models has attracted attention, and research findings indicated that it has accuracy equal to or superior to that of dermatologists in differentiating among skin lesions. While deep learning-based image diagnosis has been successful in detecting melanoma, there has been insufficient research into benign and malignant pigmented lesions on the face that are directly related to laser treatment planning, and therefore there is a need for the development of a diagnostic support system.
3. Content
The research team developed a classification system using deep learning models, InceptionResNetV2 and DenseNet121, to identify five types of facial pigmented lesions (melasma, ephelides, acquired dermal melanocytosis, solar lentigo, and and lentigo maligna/lentigo maligna melanoma). Training and validation were performed using 432 clinical images, and their diagnostic accuracies were compared to the diagnoses of 9 board-certified dermatologists (experts) and 11 noncertified dermatologists (non-experts). Both models demonstrated diagnostic accuracies of 87% and 86%, respectively. Both models overperformed the median diagnostic accuracy of 80% for experts and 63% for non-experts. Especially in identifying LM/LMM, both models achieved 100% sensitivity, suggesting its potential use as a diagnostic support tool in clinical practice.
Based on these results, the developed deep learning models far surpass the accuracy of dermatologists in diagnosing facial pigmented lesions and may contribute to diagnostic support and determining appropriate treatment plans.
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-07-01
Researchers from Shenzhen Technology University and collaborative institutions, led by Professor Guangye Zhang, have achieved a major milestone in organic solar cell (OSC) technology. Their latest work, published in Nano-Micro Letters, introduces a novel additive engineering strategy that enables 20.0% power conversion efficiency (PCE) in binary OSCs processed entirely with non-halogenated solvents. This advancement not only sets a new benchmark for toluene-processed OSCs but also offers a scalable and eco-friendly approach aligned with industrialization needs.
Why This Innovation Matters
Certified ...
2025-07-01
Award-winning author and University of South Australia academic Dr Debra Dank has unveiled her latest work, Terraglossia, a powerful response to colonial oppression that invites all Australians to reimagine how we engage with the world’s oldest living culture.
Dr Dank, a Gudanji/Wakaja and Kalkadoon woman from the Barkley Tablelands in the Northern Territory, launched the compelling follow-up to her acclaimed memoir, We Come With This Place, to challenge entrenched narratives and celebrate the richness of First Nations language and culture.
The title of the small hardback, Terraglossia, ...
2025-07-01
Subscribe to UCSF News
A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.
Type 2 diabetes (T2D), a condition in which the body can’t use insulin to clear sugar from the bloodstream, affects 1 in 10 Americans. It comes with grave health risks, including cardiovascular and kidney disease.
The study assessed medications that patients received within a year of T2D diagnosis. During the period under review — ...
2025-06-30
Scientists at the National Institutes of Health (NIH) have found that two common types of hormone therapy may alter breast cancer risk in women before age 55. Researchers discovered that women treated with unopposed estrogen hormone therapy (E-HT) were less likely to develop the disease than those who did not use hormone therapy. They also found that women treated with estrogen plus progestin hormone therapy (EP-HT) were more likely to develop breast cancer than women who did not use hormone therapy. Together, these results could help to guide clinical recommendations for hormone therapy use among younger women.
The two hormone therapies analyzed in the study are ...
2025-06-30
For people recovering from substance use disorders, quitting smoking remains one of the most difficult—but most crucial—steps toward long-term health.
New research from Flinders University reveals that providing consistent support and access to a range of nicotine replacement therapies (NRTs) can help people in recovery take that vital step.
A first-of-its-kind trial to compare vapes with combination nicotine replacement therapy (cNRT) - patches, gum, and lozenges - in people leaving smoke-free ...
2025-06-30
(Boston)—While severe maternal hypothyroidism (low thyroid hormone levels) in pregnancy is known to increase risks of adverse pregnancy outcomes, it is unclear whether mild (subclinical) hypothyroidism causes similarly adverse pregnancy complications. It is also not clear whether maternal hypothyroidism in pregnancy increases risks of gestational diabetes.
A new study in the journal Lancet Diabetes and Endocrinology (Osinga et al “Association of gestational thyroid function and thyroid ...
2025-06-30
A new study published in The Lancet has raised urgent concerns about the global health consequences of recent cuts to U.S. foreign aid. The study, coordinated by researchers from the Barcelona Institute for Global Health (ISGlobal), together with the Institute of Collective Health of the Federal University of Bahia (ISC-UFBA), the University of California Los Angeles (UCLA), and the Manhiça Centre for Health Research (CISM), among others, estimates that 91 million deaths were prevented between 2001 and 2021 in low- and middle-income countries (LMICs) thanks to programs supported by the United States ...
2025-06-30
(Tuesday 1 July 2025, London, United Kingdom) New research, presented at the ESOT Congress 2025, reveals persistent inequalities in children’s access to life-saving kidney transplants across the UK. The study highlights how ethnicity, socioeconomic status, and gender significantly influence a child's likelihood of receiving a transplant.1
Researchers from the University of Bristol analysed national data from the UK Renal Registry and NHS Blood & Transplant, focusing on patients under 18 years who started kidney replacement therapy between 1996 and 2020.2 Their findings reveal concerning disparities ...
2025-06-30
(Paris, France, Tuesday, 1 July 2025) Novel research presented today at the 41st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) has found that embryos from women with polycystic ovary syndrome (PCOS) carry a distinctive ‘epigenetic memory’ that could explain why the condition often runs in families.[1]
PCOS is a common hormonal disorder affecting an estimated 1 in 10 women of reproductive age worldwide.[2] It is characterised by irregular menstrual cycles, excess levels of androgens (male hormones) and the presence of multiple cysts on the ovaries.[3] While it is recognised as a leading ...
2025-06-30
(Paris, France, Tuesday, 1 July 2025) Fewer in vitro fertilisation (IVF) and intrauterine insemination (IUI) cycles were reported in Europe in 20202, but clinical pregnancy rates remained stable, according to data presented at the 41st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) [1].
Preliminary data from the ESHRE European IVF Monitoring (EIM) Consortium [2] reveals a steady and progressive rise in the use of Assisted Reproductive Technology (ART). In 2022, a total of 960,347 ART treatment cycles were reported by 1,371 clinics across 39 European countries, a 15.6% reduction from the 1,137,177 cycles reported in 2021 [3].
Of ...
LAST 30 PRESS RELEASES:
[Press-News.org] Developed an AI-based classification system for facial pigmented lesions
Supporting laser treatment decisions: Potential for more optimized treatment